视力障碍市场：依产品类型、最终用户、地区

预计2024年全球视力障碍市场规模为48.1亿美元，2031年将达86.9亿美元，2024年至2031年复合年增长率为8.8%。

图：2024 年视力障碍市场占有率（%），依地区划分

预计 2024 年至 2031 年全球视力障碍市场将出现强劲成长。视力障碍是指因疾病、残疾或受伤而无法透过眼镜等正常手段矫正的视力限制。视力丧失的常见原因包括白内障、青光眼、老龄化黄斑部病变和糖尿病性视网膜病变。全球人口快速老化、糖尿病盛行率上升和都市化是推动全球视力障碍市场的关键因素。然而，高昂的治疗成本和农村地区的意识低下阻碍了市场的成长。干细胞疗法和基因疗法等创新疗法有望治疗传统方法无法解决的病症，从而开闢新的途径。

市场动态：

全球视力障碍市场是由老年人口迅速增加推动的，老年人口更容易患眼科疾病。据联合国称，到2050年，60岁及以上的人口预计将增加一倍以上，达到近21亿人。糖尿病盛行率的上升也将提振市场。据IDF称，2019年，全球9.3%的成年人患有糖尿病，预计到2045年这一比例将上升至10.9%。都市化带来了不健康的生活习惯，例如过度使用数位设备，这会导致眼睛疲劳并增加近视的风险，尤其是在年轻人中。然而，先进治疗的高昂成本、偏远地区获得医疗服务的机会有限以及意识低正在阻碍市场成长。开发干细胞和基因疗法来治疗传统方法无法解决的慢性眼部疾病提供了利润丰厚的机会。

本研究的主要特点

• 本报告对全球视力障碍市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
• 根据公司亮点、产品系列、主要亮点、绩效和策略等参数，包括全球视力障碍市场主要企业的概况。
• 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于全球视力障碍市场分析的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球视力障碍市场 – 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章全球视力障碍市场，依产品类型，2019-2031（十亿美元）

• 介绍
• 教育设备和软体
• 点字复印机和点字书写机
• 点字电脑
• 数学和科学设备
• 阅读机
• 其他的
• 行动装置
• 甘蔗
• 其他的
• 低视力装置
• 智慧眼镜
• VTS连结
• 放大镜
• 其他的
• 其他的

第六章 全球视力障碍市场，依最终使用者划分，2019-2031 年（十亿美元）

• 介绍
• 盲人学校及培训设施
• 企业和社会组织
• 个人使用
• 医院
• 其他的

第七章 2019-2031 年全球视力障碍市场（按地区）（十亿美元）

• 介绍
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

第八章 竞争格局

• 公司简介
  • OrCam Technologies
  • Sangamo Therapeutics, Inc.
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems（EVS）
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

第9章 兴衰

• 上升和下降
• 综合机会图

第10章 参考文献与调查方法

• 参考
• 调查方法

The global visual impairment market is estimated to be valued at USD 4.81 Bn in 2024 and is expected to reach USD 8.69 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

Figure. Visual Impairment Market Share (%), By Region 2024

Global visual impairment market is projected to witness robust growth during 2024-2031. Visual impairment refers to a limitation in the ability to see caused due to diseases, disorders, or injuries which cannot be corrected by usual means like glasses. Some common causes of visual impairment include cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy among others. Rapidly aging global population, rising prevalence of diabetes, and urbanization are the key factors driving the global visual impairment market. However, high cost of treatment and lack of awareness in rural areas hinders the market growth. New innovations in treatments like stem cell therapy and gene therapy holds promise to treat conditions not addressable by conventional methods, thereby opening new avenues.

Market Dynamics:

The global visual impairment market is driven by the rapidly growing geriatric population which are more prone to eye diseases. As per UN, United Nations the number of people aged 60 years and older is expected to more than double by 2050 and reach nearly 2.1 billion. Rising prevalence of diabetes also fuels the market. According to IDF, 9.3% of the global adult population had diabetes in 2019 and it is projected to rise to 10.9% by 2045. Urbanization leads to unhealthy lifestyle habits like the overuse of digital devices which strains eyes and increases risk of myopia especially among the younger population. However, high cost of advanced treatments, limited healthcare access in remote areas, and lack of awareness hinders the market growth. Development of stem cell therapy and gene therapy to treat chronic eye conditions not addressable by traditional methods offers lucrative opportunities.

Key Features of the Study:

• This report provides in-depth analysis of the global visual impairment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global visual impairment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis AG, Bausch Health Companies Inc., Acucela Inc., Nicox SA, Santen Pharmaceutical Co. Ltd., Allergan, and F. Hoffmann-La Roche AG
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global visual impairment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visual impairment market

Detailed Segmentation-

• By Product Type
  • Educational Devices & Software:
  • Braille Duplicators and Writers
  • Braille Computers
  • Mathematical & Science Devices
  • Reading Machines
  • Others
  • Mobility Devices
  • Canes
  • Others
  • Low Vision Devices
  • Smart Glasses
  • VTS Link
  • Magnifying Lenses
  • Others
  • Others
• By End Users
  • Blind Schools & Training institutes
  • Enterprises & Social Organizations
  • Personal Use
  • Hospitals
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • OrCam Technologies
  • Freedom Scientific, Inc.
  • HumanWare Group
  • Enhanced Vision Systems (EVS)
  • Vispero
  • Eschenbach Optik GmbH
  • LVI Low Vision International
  • eSight Corporation
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Visual Impairment Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Visual Impairment Market, By Product Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Educational Devices & Software
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Braille Duplicators and Writers
• Braille Computers
• Mathematical & Science Devices
• Reading Machines
• Others
• Mobility Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Canes
• Others
• Low Vision Devices
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Smart Glasses
• VTS Link
• Magnifying Lenses
• Others
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Visual Impairment Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Blind Schools & Training institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Enterprises & Social Organizations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Personal Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Visual Impairment Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • OrCam Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sangamo Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Freedom Scientific, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • HumanWare Group
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Enhanced Vision Systems (EVS)
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Vispero
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eschenbach Optik GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • LVI Low Vision International
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • eSight Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • IrisVision
  • Rejoin Technology Co., Ltd
  • Zoomax Technology Co., Limited
  • Dolphin Computer Access Ltd
  • Aumed Group Corp.
  • Topcon Corporation
  • Microsoft Corporation
  • NovaVision, Inc.
  • Telesensory Corporation
  • Second Sight Medical Products, Inc.

9. Wheel of Fortune

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact